Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT00792688
Other study ID # GLYC-101-1b
Secondary ID
Status Completed
Phase Phase 2
First received
Last updated
Start date October 2008
Est. completion date January 2010

Study information

Verified date October 2021
Source TR Therapeutics
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The primary objectives of this study are to evaluate safety and efficacy of topically applied Glucoprime gel (GLYC-101, 0.1% and GLYC-101, 1.0%) in promoting wound healing in cosmetic surgery patients undergoing Carbon Dioxide Laser Skin Resurfacing (CO2 LSR) of the lower eyelids. The study will observe the effects of the topical agent over the course of 1 month following the initial treatment.


Recruitment information / eligibility

Status Completed
Enrollment 26
Est. completion date January 2010
Est. primary completion date January 2010
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 25 Years to 70 Years
Eligibility Inclusion Criteria: - Male and female healthy volunteer subjects, between 25 and 70 years of age, giving informed consent for facial laser ablation of the lower eyelid areas for the purpose of wrinkle removal. - Lower eyelid skin is free of any irritation, scarring or dermatologic conditions which might interfere with the study. - Willing and able to participate in the study and follow all study directions. - Able to read, understand and sign the consent form prior to any study related procedures. Exclusion Criteria: - Female subjects who are pregnant, nursing, or planning a pregnancy during the course of the study, as determined by the interview and a urine pregnancy test. - Presence of irritation or dermatologic skin conditions in the lower eyelid area. - Known allergies to materials within the test formulations (i.e., yeast and/or yeast products). - Use of topical or systemic drugs (corticosteroids, retinoids, immune modulators, immune suppressants, drugs with potential for contact dermatitis, drugs with potential for skin discoloration) that may have an effect on wound healing or may impact skin pigmentation. - A history, upon wounding, of developing thickened scars, keloids, or excessive pigment change. - An unstable or severe inter-current medical condition that, in the opinion of the investigator, might interfere with interpretation of study results or render the subject at high risk for treatment complications. - Use of any investigational medication or device for any indication within 30 days of screening.

Study Design


Related Conditions & MeSH terms


Intervention

Drug:
GLYC-101 Gel (0.1%)
Topical administration to the laser-ablated area on days 1 (day of laser ablation), 2, 3, 4, and 5.
GLYC-101 Gel (1.0%)
Topical administration to the laser-ablated area on days 1 (day of laser ablation), 2, 3, 4, and 5.
GLYC-101 Placebo
Topical administration to the laser-ablated area on days 1 (day of laser ablation), 2, 3, 4, and 5.

Locations

Country Name City State
United States CLINICAL TESTING CENTER of BEVERLY HILLS Beverly Hills California

Sponsors (1)

Lead Sponsor Collaborator
TR Therapeutics

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Time to Complete Wound Closure (Epithelialization) Subjects were evaluated daily from the time of the laser procedure and initial application of test article until the subject's wounds reached 100% epithelialization. Efficacy was assessed based on the time to complete epithelialization in terms of the number of days from Day 1 (day of laser ablation) to the day on which complete epithelialization was observed. Over the course of 1 month following the initial treatment.
Secondary Cosmesis/11-point Likert Scale The cosmetic effect on each lower eyelid using an 11-point Likert Scale (0 = not healed and 10 = healed). At 1 month following the initial treatment.
See also
  Status Clinical Trial Phase
Completed NCT02865902 - Low-level Laser Therapy in Enhancing Wound Healing and Preserving Tissue Thickness N/A
Completed NCT01227759 - Tyrosur® Gel-Investigation on Wound Healing Efficacy Phase 2
Terminated NCT01191567 - Negative Pressure Wound Therapy. Therapy Effects and the Impact on the Patient's Quality of Life N/A
Recruiting NCT00737425 - Safety and Efficacy Study of Pain Shield Device to Treat Subjects Following Laparoscopic-Assisted Abdominal Surgery Phase 4
Completed NCT00746109 - Study of Wound Packing After Superficial Skin Abscess Drainage Phase 4
Terminated NCT00762138 - The AutoloGelâ„¢ Post-Market Surveillance (TAPS) Program N/A
Withdrawn NCT00234559 - Trial of Vacuum Assisted Closure® Therapy Versus Control Therapy in Angiogenesis N/A
Not yet recruiting NCT03872544 - Short Term Status of Free Dermal Fat Autografts for Complex Craniofacial Wounds
Enrolling by invitation NCT03880188 - Long Term Status of Free Dermal Fat Autografts for Complex Craniofacial Wounds
Recruiting NCT05588583 - A Clinical Investigation to Follow the Progress of Exuding Chronic Wounds Using Mepilex® Up as the Primary Dressing. N/A
Completed NCT02591537 - OxyGenesys Dissolved Oxygen Dressing; Abdominoplasty at Northwestern University N/A
Recruiting NCT05608317 - A Clinical Investigation to Follow the Progress of Exuding Chronic Venous Leg Ulcers Using a Non-Bordered Foam Dressing N/A
Recruiting NCT02195063 - Survey Study for Pain Management, Wound Care, Scar Care or UDT Phase 4
Completed NCT01319149 - A Study of the Effects of Molecular Diagnostic Directed Wound Gels on Wound Care Outcomes N/A
Completed NCT00153452 - Workplace Productivity of Persons Who Use Controlling Behavior With Intimate Partners N/A
Completed NCT06083740 - A Postmarket Clinical Follow Up Study (PMCF) to Evaluate the Safety and Performance of VERIFORTE/Granudacyn® Med Wound Irrigation Solution.
Not yet recruiting NCT02672280 - Safety and Exploratory Efficacy Study of Collagen Membrane With Mesenchymal Stem Cells in the Treatment of Skin Defects Phase 1/Phase 2
Withdrawn NCT02314416 - Stem Cells In Wound Healing With Collagen Matrix as a Carrier Phase 4
Recruiting NCT01454167 - Acid Base and Electrolytes Patterns in Drains Operational Wounds and Its Relation to Complications N/A
Completed NCT01921725 - The Clinical Application and Efficacy Verification of an Innovative Carbon Fiber Dressing N/A